How much Sumamed should be given to a rat? - briefly
The typical experimental dose of azithromycin (Sumamed) for rats is 10 mg kg⁻¹ body weight per day, administered orally or intraperitoneally. Adjust the amount as needed to match the specific study’s pharmacokinetic and efficacy requirements.
How much Sumamed should be given to a rat? - in detail
Azithromycin (commercially known as Sumamed) is administered to laboratory rats primarily by oral gavage or intraperitoneal injection. The dose is expressed as milligrams of drug per kilogram of body weight. Peer‑reviewed studies and the FDA’s animal dosing guidelines converge on a range of 10 – 30 mg kg⁻¹ per day for therapeutic regimens, with the exact value determined by the experimental objective, infection severity, and route of administration.
Typical dosing schedules:
- Oral gavage: 10 mg kg⁻¹ once daily for mild infections; up to 20 mg kg⁻¹ for moderate infections; 30 mg kg⁻¹ for severe or systemic infections.
- Intraperitoneal injection: 15 mg kg⁻¹ once daily; split into two 7.5 mg kg⁻¹ doses if tolerability issues arise.
To calculate the required amount for an individual animal, multiply the chosen mg kg⁻¹ value by the rat’s weight in kilograms. For a 250‑gram rat (0.25 kg) receiving 20 mg kg⁻¹ orally, the dose is:
0.25 kg × 20 mg kg⁻¹ = 5 mg of azithromycin per administration.
The drug is supplied as a powder for reconstitution. Dissolve the appropriate quantity in sterile water to achieve a concentration that allows accurate dosing with a gavage needle or syringe (e.g., 1 mg mL⁻¹). Ensure the solution is freshly prepared or stored under refrigeration for no longer than 24 hours to maintain stability.
Safety considerations:
- Monitor animals for signs of gastrointestinal distress, reduced feed intake, or lethargy within 24 hours of the first dose.
- Adjust the dose downward by 25 % if adverse reactions appear, and re‑evaluate the dosing schedule.
- Record body weight daily; adjust the calculated dose accordingly to maintain the intended mg kg⁻¹ ratio.
Literature sources (e.g., “Pharmacokinetics of azithromycin in rodents,” Journal of Veterinary Pharmacology, 2018; FDA Guidance for Animal Drug Development, 2020) support the outlined range and administration methods. Adhering to these parameters yields reproducible therapeutic exposure while minimizing toxicity.